In vivo studies on the mechanism of the antifibrinolytic action of E-aminocaproic acid (EACA).
D000614:Aminocaproates / Q000494:pharmacology*; D000818:Animals; D000933:Antifibrinolytic Agents; D002364:Caseins; D002417:Cattle; D003545:Cysteine; D005176:Factor XIII; D005341:Fibrinolysin / Q000378:metabolism; D005342:Fibrinolysis; D005343:Fibrinolytic Agents; D006801:Humans; D010958:Plasminogen; D013300:Streptokinase; D014238:Trichloroacetic Acid; D014443:Tyrosine / Q000378:metabolism
D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D002364:Caseins; D005343:Fibrinolytic Agents; D014443:Tyrosine; D014238:Trichloroacetic Acid; D010958:Plasminogen; D005176:Factor XIII; D013300:Streptokinase; D005341:Fibrinolysin; D003545:Cysteine